Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

August 9, 2017

Antidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. Antidepressant use has previously been linked with an increased risk of falls and hip fractures, but the risk of head injuries has not been studied before. The results were published in Alzheimer's Research & Therapy.

Antidepressant use was associated with a higher risk of especially at the beginning of use – during the first 30 days –, but the risk persisted even longer, up to two years. The association was also confirmed in a study design comparing time periods within the same person, thus eliminating selective factors. The association with traumatic brain injuries was not as clear as for head injuries, which may be due to a smaller number of these events in the study population. The use of other psychotropic drugs did not explain the observed associations.

Head injuries are more common among older people than younger ones, and they are usually caused by falling. As antidepressant use has previously been associated with an increased risk of falling, the researchers were not surprised that the use of antidepressants also increased the risk of head injuries.

"However, our findings give cause for concern because persons with Alzheimer's disease frequently use antidepressants, which have been considered a safer alternative to, for example, benzodiazepines," says Senior Researcher Heidi Taipale from the University of Eastern Finland.

"Our study population consisted of persons diagnosed with Alzheimer's disease, but it is likely that the is similar also in other older persons without Alzheimer's disease. This is something we will be studying in the future."

The study constitutes part of the nationwide register-based MEDALZ study, which includes all community-dwelling persons diagnosed with Alzheimer's disease in Finland during 2005-2011. The study included 10,910 antidepressant users and 21,820 nonusers, all of whom had Alzheimer's disease.

Explore further: Antiulcer drugs do not increase risk of Alzheimer's disease

More information: Heidi Taipale et al. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study, Alzheimer's Research & Therapy (2017). DOI: 10.1186/s13195-017-0285-3

Related Stories

Antiulcer drugs do not increase risk of Alzheimer's disease

August 7, 2017
The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland. Proton pump inhibitors are a type of antiulcer drug that is commonly used among ...

Antidepressant use increases hip fracture risk among elderly

January 11, 2017
Antidepressant use nearly doubles the risk of hip fracture among community-dwelling persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The increased risk was highest at the ...

Antidepressant use begins years before Alzheimer's diagnosis

March 4, 2016
Antidepressants are frequently prescribed to persons with Alzheimer's disease before the diagnosis, according to a recent study from the University of Eastern Finland. Among persons with Alzheimer's disease, the initiation ...

More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

October 3, 2016
Psychotropic drug use is rather common among persons aged 90 years or more diagnosed with Alzheimer's disease, compared with those who were diagnosed at younger age, concludes a study conducted at the University of Eastern ...

Benzodiazepines and related drugs increase stroke risk among persons with Alzheimer's disease

January 16, 2017
The use of benzodiazepines and benzodiazepine-like drugs was associated with a 20 per cent increased risk of stroke among persons with Alzheimer's disease, shows a recent study from the University of Eastern Finland. Benzodiazepines ...

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

December 7, 2016
The hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Eastern Finland. However, the incidence of hip fracture is higher among ...

Recommended for you

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease

December 5, 2017
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.